In Nov. 2022, the U.S. nonprofit Multidisciplinary Association for Psychedelic research (MAPS) declared that it had concluded a next phase-3 trial on MDMA to be a treatment for PTSD—a move extensively noticed as the final hurdle to apparent right before making use of for acceptance from the U.S. food stuff and Drug Administration (FDA). whilst th